Aromasin 25mg Tablet
PDF Leaflet Revision Date: 02 February 2007
Clinical Summary
Quick overview from the medicine insert
Indication
Advanced oestrogen receptor positive breast cancer in postmenopausal women.
Dosage (summary)
25 mg once daily after a meal.
Special Populations
- Renal insufficiency
- Hepatic insufficiency
Pregnancy & Breastfeeding
Contra-indicated in pregnancy and lactation.
Key Drug Interactions
- CYP 3A4 inducers
- Oestrogen-containing medicines
Contraindications
- Hypersensitivity to exemestane
- Premenopausal women
- Pregnant or lactating women
Common side effects
- Hot flushes
- Fatigue
- Nausea
- Insomnia
- Headache
Counselling Points
- Take after a meal
- Monitor bone mineral density if at risk for osteoporosis
Serious warnings
- Drowsiness and dizziness may impair driving
- Assess postmenopausal status before use
Important Disclaimer
The Aromasin 25mg Tablet professional information leaflet below is the property of Pfizer and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
